Kry is Europe’s largest digital healthcare provider, allowing patients to see a doctor, nurse, or psychologist through video consultations within minutes.
We’ve delivered 11+ million patient appointments transforming access to high quality care at scale. Above all else, we’re driven by our vision of great healthcare for everyone.
Headquartered in Stockholm and backed by some of Europe’s most renowned investors, our employees and 3000+ healthcare professionals are committed to improving the world’s health through innovation, one patient at a time.
Through our products, we’re harnessing the power of technology to integrate, primary, urgent and secondary care within digital and physical care settings so patients connect to the right care, at the right time. We work with partners to tailor member journeys and with public health systems to deliver efficient care, at a lower cost.
In Sweden and Norway you may know us as Kry. In the UK and France we operate under the name Livi.
To learn more, visit www.kry.se / www.livi.co.uk / www.livi.fr / www.kry.no
Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas where infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access.
Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.
Bactiguard is headquartered in Stockholm and is listed on Nasdaq Stockholm and is included in the Mid-Cap segment.